Author(s): Mayur S. Jain, Shashikant D. Barhate


DOI: Not Available

Address: Mr. Mayur S. Jain*, Dr. Shashikant D. Barhate
Shree Sureshadada Jain Institutes of Pharmaceutical Education and Research, Jammer, Maharashtra (India).
*Corresponding Author

Published In:   Volume - 11,      Issue - 1,     Year - 2021

Cite this article:
Mayur S. Jain, Shashikant D. Barhate. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19: A Review. 10.5958/2231-5691.2021.00008.3

Recomonded Articles:

Author(s): Krushna K. Zambare, Avinash B. Thalkari

DOI: 10.5958/2231-5691.2019.00028.5         Access: Open Access Read More

Author(s): Ravi Kumar, Sanjeev Saini, Chatter Singh, Bijander Singh, Alimuddin Saifi

DOI: 10.5958/2231-5691.2020.00022.2         Access: Open Access Read More

Author(s): Rahul D. Shimpi, Shashikant D. Barhate, Mayur S. Jain

DOI: 10.52711/2231-5691.2023.00013         Access: Closed Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 

Recent Articles